JRI 
Vol. 22, Issue 4, / October-December 2021
(Case Report, pages 302-306)
PMID: 34987993 (PubMed) - PMCID: PMC8669406

Haseena Sait
- Department of Medical Genetics, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow , India
Priyanka Srivastava
- Department of Medical Genetics, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow , India
Preeti Dabadghao
- Department of Endocrinology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow , India
Shubha R Phadke Corresponding Author
- Department of Medical Genetics, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow , India

Received: 8/28/2020 Accepted: 12/15/2020 - Publisher : Avicenna Research Institute

Related Articles

 

Other Format

 


Abstract

Background: Xp22.3 region is characterized by low frequency of interspersed repeats and low GC content. Several clinically important genes including ANOS1 (KAL1) reside in this region. This gene was first identified due to translocation between chromosomes X and Y in a patient with Kallmann syndrome.
Case Presentation: A 20 year old male presented with complaints of delayed secondary sexual characteristics, impaired sense of smell, and poor scholastic performance. On examination, he had short stature (151 cm; <3rd centile). His sexual maturity corresponded to Tanner stage 3. Stretched penile length was 3.6 cm (<3rd centile). Right testis was undescended with low left testicular volume (12 ml). There was mild ichthyosis over abdomen and back. He had hyposmia, hoarse voice, and synkinesia. Investigations were suggestive of hypogonadotrophic hypogonadism. Karyotype revealed an extra chromosomal material on p arm of chromosome X (46,Xp+,Y). On cytogenetic microarray, deletion of 8.3 Mb on Xp22.33 region and duplication of 12.8 Mb on Yq11.22 region were identified. The breakpoint on X chromosome resulted in deletion of exons 7-14 of ANOS1 gene and complete STS, NLGN4X, ARSL (ARSE), SHOX, and VCX genes.
Conclusion: Patients diagnosed with Kallmann syndrome should receive careful clinical evaluation to detect presence of a contiguous gene syndrome.



Keywords: Hypogonadism, Hyposmia, Ichthyosis, Kallmann syndrome, Stunting


To cite this article:


Full Text

Introduction
Large terminal or interstitial deletions of the Xp22.3 region involving ANOS1 (KAL1) and adjacent genes results in "contiguous gene syndrome". The rare co-occurrence of Kallmann syndrome and X- linked ichthyosis can be explained by this phenomenon. In this report, a case of Kallmann syndrome was described which is caused by deletion of exons 7-14 of ANOS1 gene due to an unbalanced translocation between chromosomes X and Y. This translocation resulted in 12.8 Mb duplication of Yq chromosome and 8.3 Mb deletion of Xp chromosome. Other clinically significant genes present in the deleted re-gion were STS, NLGN4X, ARSL (ARSE), SHOX, and VCX.

Case Presentation
A 20 year old male (Figures 1A and B) was referred to the department of medical genetics of a tertiary care institute on the 16th of June, 2018. His chief complaints were delayed secondary sexual characteristics, impaired sense of smell, and poor scholastic performance. He was born of non-consanguineous marriage. Family history was not significant. His weight was 60 kg (0 SD) and height was 151 cm (<-3 Z score). He had narrow palpebral fissures, eunuchoid appearance, gynecomastia, and sexual maturity rating corresponded to Tanner stage 3. His right testis was not identified in the scrotum or inguinal canal and left testicular volume was low (12 ml). Stretched penile length was 3.6 cm (<3rd centile). mild ichthyosis on abdomen (figure 1c) and back was observed. he did not have any significant facial dysmorphism or any other malformation. central nervous system examination revealed hyposmia, hoarse voice, and synkinesia of hands.
Endocrinological evaluation was suggestive of hypogonadotrophic hypogonadism [FSH: 0.733 IU/L, LH: <0.1 IU/L (normal value: 1.7-8.6) and testosterone: 5.59 nmol/L (normal value: 8.6-29)]. Skeletal survey did not reveal any significant findings. Karyotype from peripheral blood lymphocytes was performed and an extra material on p arm of chromosome X was identified (46,Xp+,Y) (Figure 1D). DNA was extracted from peripheral blood and cytogenetic microarray was performed by Cytoscan 750 K array kit (Affymetrix, USA). A 8.3 Mb deletion on short arm of chromosome X {arr[hg19] Xp22.33p22.31(168,551-8,538,809)} including 37 OMIM genes and a 12.8 Mb duplication on long arm of chromosome Y {arr[hg19] Yq11.221q11.23(15,999,473-28,799,654)} including 25 OMIM genes were identified (Figures 1E and F). The breakpoint on X chromosome resulted in deletion of important and clinically relevant genes including ANOS1 (KAL1) gene (7th-14th exon), STS gene, and 4 other genes including SHOX, ARSL(ARSE), NLGN4X, and VCX (Figure 1F). The duplicated Y segment contained only one clinically important gene namely, DAZ1. Duplication of DAZ1 has not been implicated in any disease causation. Parental blood samples were not available to identify the inherited characteristics of this chromosomal aberration. However, both parents were clinically normal and fertile.

Discussion
Identification of contiguous gene syndromes has led to the establishment of chromosomal location of a number of disease loci. The Xp22.3 region is characterized by low frequency of interspersed repeats and a low GC content. This region contains several important genes including ANOS1 (KAL1), STS, PNPLA4, NLGN4X, ARSL (ARSE), SHOX, and VCX cluster (1). A large region of homologous sequences has been identified on Xp22.3 and Yq11 chromosomes. This sequence similarity often facilitates aberrant X-Y pairing during male meiosis and causes X-Y translocation. This in turn results in terminal or interstitial deletions of Xp22.3 region (2). The first case of X-Y translocation was observed in a female with reproductive failure (3) and in a male with severe mental retardation and short stature (4).
The preliminary investigation in our patient with karyotype revealed an extra material on the p arm of X chromosome. Cytogenetic microarray confirmed the origin of this material to be a duplicated segment of long arm of Y chromosome.  It also delineated the exact region of breakpoint on the X chromosome due to this translocation and deletion of clinically important genes like ANOS1 (KAL1), STS, and other genes. The parent’s karyotype was not done but the derivative chromosome of this character is unlikely to be inherited as its presence will cause infertility in XX or XY individual. Individual with der(X), X will have phenotype of Klinefelter syndrome while a male with der(X), Y will be infertile like our patient.
The X- linked form of Kallmann syndrome was mapped to Xp22.3 region. Studies have described patients with variable deletions of distal short arm of chromosome resulting in complex clinical features combining Kallmann syndrome, X-linked ichthyosis, chondrodysplasia punctata, ocular albinism, short stature, and mental retardation (Table 1). In our study, the patient predominantly had clinical features of Kallmann syndrome and ichthyosis. Other clinical findings observed in our patient and the probable genes involved are tabulated (Table 2).
Moreover, an attempt was made in this study to review the literature to identify the cases of Kallmann syndrome caused by chromosomal aberrations (Table 1). Ballabio et al. (5) were the first group who confirmed the hypothesis of contiguous gene syndrome in deletions involving distal short arm of chromosome X and constructed a disease map of this region. They enrolled 16 male patients showing variable deletions in Xp22-pter region identified on the karyotype and then used specific molecular probes and southern blotting technique to refine the chromosomal region of Kallmann syndrome and other disease genes. However, cytogenetic microarray was employed in only three recently reported cases to confirm the involvement of contiguous genes in this region (Table 1).
The 8.3 Mb deletion on Xp22.3 region in our case is the second largest deletion reported till date amongst the cases of Kallmann syndrome caused by chromosomal aberrations. While majority of cases reported in literature show the complete deletion of KAL1 gene, few case reports have also described partial gene deletions (Table 1) in Kallman syndrome similar to our case.

Conclusion
To conclude, patients presenting with features of Kallmann syndrome should be carefully evaluated for other clinical features like ichthyosis and short stature. This would further help in tailoring the investigational approach for this disorder and screening for other comorbidities.

Conflict of Interest
Authors declare no conflict of interest.




Figures, Charts, Tables

High Resolution
Figurer 1. A, B) Patient with Kallmann syndrome, C) Mild ichthyosiform lesion in the abdomen, D) Karyotype report of the patient showing extra material on p arm of chromosome X, E) Cytogenetic microarray of the patient showing complete deletion of STS gene and partial deletion of ANOS1 (KAL1) gene, respectively, F) Ideograms of chromosomes X and Y showing deleted (Red inverted triangle) and duplicated segments (Blue triangle) on chromosomes X and Y, G) Diagrammatic representation of breakpoint on X chromosomes showing deletions of exons 7-14 of ANOS1 gene

Figurer 1. A, B) Patient with Kallmann syndrome, C) Mild ichthyosiform lesion in the abdomen, D) Karyotype report of the patient showing extra material on p arm of chromosome X, E) Cytogenetic microarray of the patient showing complete deletion of STS gene and partial deletion of ANOS1 (KAL1) gene, respectively, F) Ideograms of chromosomes X and Y showing deleted (Red inverted triangle) and duplicated segments (Blue triangle) on chromosomes X and Y, G) Diagrammatic representation of breakpoint on X chromosomes showing deletions of exons 7-14 of ANOS1 gene




Table 1. Review of literature on clinical features of patients and molecular techniques used in contiguous gene syndrome

Table 1. Review of literature on clinical features of patients and molecular techniques used in contiguous gene syndrome




Table 2. Genes deleted due to Xp22.33p22.31 involvement and findings in our patient
&#8270; The characteristic epiphyseal stippling disappears after 3 years of age and other skeletal findings improve by adulthood. Incomplete penetrance seen
# Clinical expression is highly variable and becomes more pronounced with age

Table 2. Genes deleted due to Xp22.33p22.31 involvement and findings in our patient
⁎ The characteristic epiphyseal stippling disappears after 3 years of age and other skeletal findings improve by adulthood. Incomplete penetrance seen
# Clinical expression is highly variable and becomes more pronounced with age



References

  1. Ross MT, Grafham DV, Coffey AJ, Scherer S, McLay K, Muzny D, et al. The DNA sequence of the human X chromosome. Nature. 2005;434(7031):325-37.   [PubMed]
  2. Guioli S, Incerti B, Zanaria E, Bardoni B, Franco B, Taylor K, et al. Kallmann syndrome due to a translocation resulting in an X/Y fusion gene. Nat Genet. 1992;1(5):337-40.   [PubMed]
  3. Khudr G, Benirschke K, Judd HL, Strauss J. Y to X translocation in a woman with reproductive failure. a new rearrangement. JAMA. 1973;226(5):544-9.   [PubMed]
  4. Bernstein R, Wagner J, Isdale J, Nurse GT, Lane AB, Jenkins T. X-Y translocation in a retarded phenotypic male. Clinical, cytogenetic, biochemical, and serogenetic studies. J Med Genet. 1978;15(6):466-74.   [PubMed]
  5. Ballabio A, Bardoni B, Carrozzo R, Andria G, Bick D, Campbell L, et al. Contiguous gene syndromes due to deletions in the distal short arm of the human X chromosome. Proc Natl Acad Sci USA. 1989;86(24):10001-5.   [PubMed]
  6. Meindl A, Hosenfeld D, Bruckl W, Schuffenhauer S, Jenderny J, Backsulin, et al. Analysis of a terminal Xp22.3 deletion in a patient with six monogenic disorders: implications for the mapping of X linked ocular albinism. J Med Genet. 1993;30(10):838-42.   [PubMed]
  7. Klink A, Meindl A, Hellbrand H, Rappold GA. A patient with an interstitial deletion in Xp22.3 locates the gene for X linked recessive chondrodysplasia punctata to within a one megabase interval. Hum Genet. 1994;93(4):463-6.   [PubMed]
  8. Parenti G, Rizzolo MG, Ghezzi M, Di Maio S, Sperandeo MP, Incerti B, et al. Variable penetrance of hypogonadism in a sibship with Kallmann syndrome due to a deletion of the KAL1 gene. Am J Med Genet. 1995;57(3):476-8.   [PubMed]
  9. Maya-Núñez G, Cuevas-Covarrubias S, Carlos Zenteno J, Ulloa-Aguirre A, Kofman-Alfaro S, Pablo Méndez JP. Contiguous gene syndrome due to deletion of the first three exons of the Kallmann gene and complete deletion of the steroid sulphatase gene. Clin Endocrinol (Oxf). 1998;48(6):713-8.   [PubMed]
  10. Lonardo F, Parenti G, Luquetti DV, Annunziata I, Monica MD, Perone L, et al. Contigous gene syndrome due to an interstitial deletion in Xp22.3 in a boy with ichthyosis, chondrodysplasia punctate, mental retardation and ADHD. Eur J Med Genet. 2007;50(4):301-8.   [PubMed]
  11. Cho EH, Kim SY, Kim JK. A case of 9.7 Mb terminal Xp deletion including OA1 locus associated with contiguous gene syndrome. J Korean Med Sci. 2012;27(10):1273-7.   [PubMed]
  12. Berges-Raso I, Giménez-Palop O, Gabau E, Capel I, Caixàs A, Rigla M. Kallmann syndrome and ichthyosis: a case of contiguous gene deletion syndrome. Endocrinol Diabetes Metab Case Rep. 2017;2017:EDM170083.   [PubMed]
  13. Nagai K, Shima H, Kamimura M, Kanno J, Suzuki E, Ishiguro A, et al. Xp22.31 microdeletion due to microhomology-mediated break-induced replication in a boy with contiguous gene deletion syndrome. Cytogenet Genome Res. 2017;151(1):1-4.   [PubMed]

COPE
SID
NLM
AJMB
IJBMLE
IJBMLE

Home | About Us | Current Issue | Past Issues | Submit a Manuscript | Instructions for Authors | Subscribe | Search | Contact Us

"Journal of Reproduction & Infertility" is owned, published, and managed by Avicenna Research Institute .
Creative Commons License

This work is licensed under a Creative Commons Attribution –NonCommercial 4.0 International License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

Journal of Reproductoin and Infertility (JRI) is a member of COMMITTEE ON PUBLICATION ETHICS . Verify here .

©2024 - eISSN : 2251-676X, ISSN : 2228-5482, For any comments and questions please contact us.